Overview

Perioperative Iron for Colorectal Cancer (PICoC Study)

Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
The PICoC study aims to investigate whether oral ferric maltol given postoperatively offers an improvement in patient and clinician reported outcomes compared to standard care.
Phase:
Phase 3
Details
Lead Sponsor:
The Royal Wolverhampton Hospitals NHS Trust
Collaborator:
Norgine
Treatments:
Ferric maltol